Workflow
医疗大数据
icon
Search documents
【每日简讯】湖北上线社科人工智能大模型 | 海南省三医大数据中心成立
Xin Lang Cai Jing· 2025-12-11 10:10
工信部印发《产业技术基础公共服务平台管理办法》 近日,工业和信息化部印发新修订的《产业技术基础公共服务平台管理办法》,包括总则、申报、审核 发布、运行、动态管理、附则等6章22项条款,自2025年12月5日起施行。《管理办法》提出,服务平台 申报单位应当明确申报的服务行业领域及服务范围。服务平台应加强自身能力建设,不断提高业务能 力、服务开放水平,结合发展实际提升数据开源共享水平,密切关注产业发展动态和技术趋势,探索新 业务模式和商业模式,及时调整、优化服务内容,强化数据应用效能,提高服务质量和服务效率,赋能 企业发展。(来源:工业和信息化部) 日前,面向哲学社会科学领域的人工智能大模型在湖北武汉正式上线。这套由湖北省社科联牵头打造 的"湖北社会科学AI模型及其应用服务项目",不仅搭载了国产、安全、可控的智能底座,更同步推出了 全国首台社科智能交互机器人"荆哲",并组建了首批"数智社科专家"团队。此举标志着湖北在推动"社 科+AI"深度融合、构建数智化社科普及新体系上迈出关键一步。 内蒙古地质矿产集团AI找矿预测获突破 构建全区首个找矿大模型专用数据集 12月9日,内蒙古地质矿产集团召开AI找矿预测成果汇报会 ...
国新健康:目前已与国内多家保险公司建立深度合作关系
Zheng Quan Ri Bao· 2025-10-21 11:38
Core Viewpoint - Guoxin Health is actively collaborating with insurance brokerage firms, health management service providers, and medical service institutions to explore a data-driven full-chain service model for health insurance, covering product design, marketing, underwriting, claims, and risk control [2] Group 1: Collaboration and Innovation - The company has established deep cooperative relationships with several domestic insurance companies to promote the implementation of innovative health insurance service models [2] - Guoxin Health is involved in projects such as the operation of public data authorization in Hangzhou and the personal medical insurance data authorization query in Pingxiang, Jiangxi, to enhance data compliance and operational practices [2] Group 2: Data Integration and Development - Guoxin Health has jointly established a company with Hubei Data Group to operate health medical big data in Central China, aiming to integrate and utilize health medical data resources within Hubei Province [2] - The newly formed company serves as a pilot for public data authorization operations in the "Three Medical" fields, facilitating the development and utilization of health medical data resources [2]
陈曦:推进药品可信数据空间建设 探索“AI+医疗”落地
Zhong Guo Jing Ji Wang· 2025-08-30 08:02
Core Insights - The construction of a national-level trusted data space for the pharmaceutical industry will follow three main strategies: government-enterprise co-management, pilot projects in subspaces, and a whitelist approach for gradual implementation [1][2] Group 1: Data Governance in Pharmaceutical Industry - The trusted data space is based on the drug traceability platform launched in 2023, which integrates data across the entire chain of drug production, distribution, and usage [1] - The focus will initially be on mature areas such as biological products, medical devices, and anesthetic drugs, with steady progress being made in these areas [1] Group 2: AI and Healthcare - Key breakthrough areas for AI in healthcare include innovative drug development, intelligent health management, and medical diagnostic assistance [1] - The potential for AI to enhance health management services and reduce misdiagnosis rates is significant, facilitated by the integration of health data [1] Group 3: Collaboration with Guizhou - The company anticipates that the Digital Expo will play a role in policy guidance, standard setting, and ecosystem collaboration within the healthcare big data sector [2] - Future collaboration with Guizhou will focus on integrating industry data spaces with urban data spaces and implementing a personal health account system [2]